TickerFacts.

IGC Pharma, Inc. (IGC): Gross Profit

Annual figures by period end, from SEC filings. For years the company left out, it is revenue minus cost of revenue, computed by TickerFacts; where both exist they agree (see each figure's source).

Computed by TickerFacts from revenue minus cost of revenue. This may differ from the issuer's reported gross profit or margin; check the revenue and cost definitions.

Not updated since 2025-03-31. No annual report in US GAAP has been filed since. Companies that switch to IFRS reporting, as many foreign filers do, or stop filing are not updated here.

$619.0K
Year ended 2025-03-31
$511.0K
Trailing 12 months to 2025-09-30
+47.2%
3-year compound annual growth
+40.0%
5-year compound annual growth
+0.7%
10-year compound annual growth
$1.53M2011-03-31: $159.3K2012-03-31: -$618.4K2013-03-31: $1.53M2014-03-31: $381.6K2015-03-31: $579.7K2016-03-31: $843.3K2017-03-31: $218.2K2018-03-31: $82.0K2019-03-31: $132.0K2020-03-31: $115.0K2021-03-31: $113.0K2022-03-31: $194.0K2023-03-31: $442.0K2024-03-31: $733.0K2025-03-31: $619.0K$619.0K
2011-03-31 Gross Profit (USD) 2025-03-31
Period endedGross ProfitChange YoYSource filing
2025-03-31$619.0K-15.6%2025-06-27, From 2024-04-01
2024-03-31$733.0K+65.8%2025-06-27, From 2023-04-01
2023-03-31$442.0K+127.8%2024-06-24, From 2022-04-01
2022-03-31$194.0K+71.7%2023-07-07, From 2021-04-01
2021-03-31$113.0K-1.7%2022-06-23, From 2020-04-01
2020-03-31$115.0K-12.9%2021-06-14, From 2019-04-01
2019-03-31$132.0K+61.0%2020-07-13, From 2018-04-01
2018-03-31$82.0K-62.4%2019-06-14, From 2017-04-01
2017-03-31$218.2K-74.1%2018-06-21, From 2016-04-01
2016-03-31$843.3K+45.5%2017-07-14, From 2015-04-01
2015-03-31$579.7K+51.9%2016-07-14, From 2014-04-01
2014-03-31$381.6K-75.1%2015-07-14, From 2013-04-01
2013-03-31$1.53Mn/m2014-07-15, From 2012-04-01
2012-03-31-$618.4Kn/m2014-07-15, From 2011-04-01
2011-03-31$159.3Kn/a2012-07-16, From 2010-04-01